Ovarian Cancer G Protein Coupled Receptor 1, a New Metastasis Suppressor Gene in Prostate Cancer
Open Access
- 28 August 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 99 (17), 1313-1327
- https://doi.org/10.1093/jnci/djm107
Abstract
Metastasis is a process by which tumors spread from primary organs to other sites in the body and is the major cause of death for cancer patients. The ovarian cancer G protein–coupled receptor 1 (OGR1) gene has been shown to be expressed at lower levels in metastatic compared with primary prostate cancer tissues. We used an orthotopic mouse metastasis model, in which we injected PC3 metastatic human prostate cancer cells stably transfected with empty vector (vector-PC3) or OGR1-expressing vector (OGR1-PC3) into the prostate lobes of athymic or NOD/SCID mice (n = 3–8 mice per group). Migration of PC3 cells transiently transfected with vector control or with OGR1- or GPR4 (a G protein–coupled receptor with the highest homology to OGR1)-expressing vectors was measured in vitro by Boyden chamber assays. G protein alpha–inhibitory subunit 1 (Gα i1 ) expression after treatment with pertussis toxin (PTX) was measured using immunoblotting analysis. The inhibitory factor present in the conditioned medium was extracted using organic solvents and analyzed by mass spectrometry. In vivo, all 26 mice carrying tumors that were derived from vector-PC3 cells developed prostate cancer metastases (mean = 100%, 95% confidence interval [CI] = 83.97% to 100%) but few (4 of 32) mice carrying tumors derived from OGR1-expressing PC3 cells (mean = 12.50%, 95% CI = 4.08% to 29.93%) developed metastases. However, exogenous OGR1 overexpression had no effect on primary prostate tumor growth in vivo. In vitro, expression of OGR1, but not GPR4, inhibited cell migration (mean percentage of cells migrated, 30.2% versus 100%, difference = 69.8%, 95% CI = 63.0% to 75.9%; P <.001) via increased expression of Gα i1 and the secretion of a chloroform/methanol–extractable heat-insensitive factor into the conditioned medium through a PTX-sensitive pathway. OGR1 is a novel metastasis suppressor gene for prostate cancer. OGR1's constitutive activity via Gα i contributes to its inhibitory effect on cell migration in vitro.Keywords
This publication has 45 references indexed in Scilit:
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- KiSS1 Suppresses Metastasis in Human Ovarian Cancer via Inhibition of Protein Kinase C AlphaClinical & Experimental Metastasis, 2005
- PERSPECTIVES ON CLASSIC ARTICLES: Metastasis Suppressor GenesJNCI Journal of the National Cancer Institute, 2004
- Models of metastatic prostate cancer: a transgenic perspectiveProstate Cancer and Prostatic Diseases, 2003
- Metastasis suppressor pathways—an evolving paradigmCancer Letters, 2003
- Metastasis Suppressor Genes: Basic Biology and Potential Clinical UseClinical Breast Cancer, 2003
- Metastasis suppressors alter the signal transduction of cancer cellsNature Reviews Cancer, 2003
- G Protein–Coupled Receptors Provide Survival Signals in Prostate CancerClinical Prostate Cancer, 2002
- Lysophosphatidic acid‐regulated mitogenic ERK signaling in androgen‐insensitive prostate cancer PC‐3 cellsInternational Journal of Cancer, 2002
- Metastasis-Suppressor Genes: a Review and Perspective on an Emerging FieldJNCI Journal of the National Cancer Institute, 2000